Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...

The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.

Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

Fasikl has received 510(k) clearance from the FDA for its Felix NeuroAI Wristband, designed to address tremor-related functional ...

Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...